{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:50:10Z","timestamp":1794473410810,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007465","name":"UiT The Arctic University of Norway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007465","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study analyzed mortality after radiotherapy for bone metastases (287 courses). Endpoints such as treatment in the last month of life and death within 30, 35 and 40\u00a0days from start of radiotherapy were evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Different baseline parameters including but not limited to blood test results and patterns of metastases were assessed for association with early death. After univariate analyses, multi-nominal logistic regression was employed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 287 treatment courses, 42 (15%) took place in the last month of life. Mortality from start of radiotherapy was 13% (30-day), 15% (35-day) and 18% (40-day), respectively. We identified three significant predictors of 30-day mortality (performance status (\u2264\u200950, 60\u201370, 80\u2013100), weight loss of at least 10% within 6\u00a0months (yes\/no), pleural effusion (present\/absent)) and employed these to construct a predictive model with 5 strata and mortality rates of 0\u201375%. All predictors of 30-day mortality were also associated with both, 35- and 40-day mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Early death was not limited to the first 30\u00a0days after start of radiotherapy. For different cut-off points, similar predictive factors emerged. A model based on three robust predictors was developed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-023-02253-0","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:07:57Z","timestamp":1680520077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors"],"prefix":"10.1186","volume":"18","author":[{"given":"Carsten","family":"Nieder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Stanisavljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e5rd","family":"Manns\u00e5ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellinor C.","family":"Haukland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"2253_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/PPO.0000000000000459","volume":"26","author":"EK Seymour","year":"2020","unstructured":"Seymour EK, de Souza JA, Fendrick AM. Incorporating value-based care into oncology. Cancer J. 2020;26:311\u201322.","journal-title":"Cancer J"},{"issue":"1","key":"2253_CR2","doi-asserted-by":"publisher","first-page":"20978","DOI":"10.1038\/s41598-022-25602-7","volume":"12","author":"CM Donati","year":"2022","unstructured":"Donati CM, Macchia G, Siepe G, Zamagni A, Benini A, Cellini F, et al. Short course palliative radiotherapy in advanced solid tumors: a pooled analysis (the SHARON project). Sci Rep. 2022;12(1):20978.","journal-title":"Sci Rep"},{"key":"2253_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.radonc.2022.07.023","volume":"175","author":"SH Kombathula","year":"2022","unstructured":"Kombathula SH, Cree A, Joshi PV, Akturk N, Barraclough LH, Haslett K, et al. Palliative radiotherapy in cancers of female genital tract: outcomes and prognostic factors. Radiother Oncol. 2022;175:42\u20136.","journal-title":"Radiother Oncol"},{"issue":"10","key":"2253_CR4","doi-asserted-by":"publisher","first-page":"10360","DOI":"10.21037\/apm-21-1779","volume":"10","author":"GS Ahn","year":"2021","unstructured":"Ahn GS, Bruggeman AR, Qiao EM, Moiseenko V, Ray X, Sharabi A, et al. Hypofractionated radiation therapy as palliative management for symptomatic and local control of advanced thoracic malignancies. Ann Palliat Med. 2021;10(10):10360\u20138.","journal-title":"Ann Palliat Med"},{"issue":"3","key":"2253_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.radonc.2017.12.011","volume":"126","author":"M Shahid Iqbal","year":"2018","unstructured":"Shahid Iqbal M, Kelly C, Kovarik J, Goranov B, Shaikh G, Morgan D, et al. Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: a systematic review. Radiother Oncol. 2018;126(3):558\u201367.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2253_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13014-022-02128-w","volume":"17","author":"K Ito","year":"2022","unstructured":"Ito K, Saito T, Nakamura N, Imano N, Hoskin P. Stereotactic body radiotherapy versus conventional radiotherapy for painful bone metastases: a systematic review and meta-analysis of randomised controlled trials. Radiat Oncol. 2022;17(1):156.","journal-title":"Radiat Oncol"},{"key":"2253_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.radonc.2022.01.030","volume":"168","author":"JH Kutzko","year":"2022","unstructured":"Kutzko JH, Dadwal P, Holt T, Rahman MA, Zahir SF, Hickey B. Defining the expected 30-day mortality for patients undergoing palliative radiotherapy: a meta-analysis. Radiother Oncol. 2022;168:147\u2013210.","journal-title":"Radiother Oncol"},{"key":"2253_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.14740\/jocmr4060","volume":"12","author":"C Nieder","year":"2020","unstructured":"Nieder C, Manns\u00e5ker B, Dalhaug A. Independent external validation of a score predicting survival after radiotherapy for bone metastases and expansion to patients treated with single fraction radiotherapy. J Clin Med Res. 2020;12:90\u20139.","journal-title":"J Clin Med Res"},{"key":"2253_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-022-02040-y","author":"C Nieder","year":"2023","unstructured":"Nieder C, Haukland EC, Mannsaker B, Dalhaug D. Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation. Strahlenther Onkol. 2023. https:\/\/doi.org\/10.1007\/s00066-022-02040-y.","journal-title":"Strahlenther Onkol"},{"key":"2253_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00066-008-1831-5","volume":"184","author":"D Rades","year":"2008","unstructured":"Rades D, Dunst J, Schild SE. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol. 2008;184:251\u20135.","journal-title":"Strahlenther Onkol"},{"key":"2253_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.ijrobp.2010.03.031","volume":"80","author":"D Rades","year":"2011","unstructured":"Rades D, Dziggel L, Haatanen T, Veninga T, Lohynska R, Dunst J, et al. Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. Int J Radiat Oncol Biol Phys. 2011;80:1122\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2253_CR12","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1200\/JCO.2006.10.5411","volume":"25","author":"S Gripp","year":"2007","unstructured":"Gripp S, Moeller S, B\u00f6lke E, Schmitt G, Matuschek C, Asgari S, et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol. 2007;25:3313\u201320.","journal-title":"J Clin Oncol"},{"key":"2253_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ijrobp.2020.05.023","volume":"108","author":"SR Alcorn","year":"2020","unstructured":"Alcorn SR, Fiksel J, Wright JL, Elledge CR, Smith TJ, Perng P, et al. Developing an improved statistical approach for survival estimation in bone metastases management: the Bone Metastases Ensemble Trees for Survival (BMETS) model. Int J Radiat Oncol Biol Phys. 2020;108:554\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2253_CR14","first-page":"877","volume":"34","author":"K Angelo","year":"2014","unstructured":"Angelo K, Norum J, Dalhaug A, Pawinski A, Aandahl G, Haukland E, et al. Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy. Anticancer Res. 2014;34:877\u201385.","journal-title":"Anticancer Res"},{"key":"2253_CR15","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1200\/JCO.2008.17.1363","volume":"26","author":"E Chow","year":"2008","unstructured":"Chow E, Abdolell M, Panzarella T, Harris K, Bezjak A, Warde P, et al. Predictive model for survival in patients with advanced cancer. J Clin Oncol. 2008;26:5863\u20139.","journal-title":"J Clin Oncol"},{"key":"2253_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/1754-9485.13185","volume":"65","author":"I Pobar","year":"2021","unstructured":"Pobar I, Job M, Holt T, Hargrave C, Hickey B. Prognostic tools for survival prediction in advanced cancer patients: a systematic review. J Med Imaging Radiat Oncol. 2021;65:806\u201316.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"2253_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13014-022-02062-x","volume":"17","author":"C Nieder","year":"2022","unstructured":"Nieder C, Stanisavljevic L, Aanes SG, Manns\u00e5ker B, Haukland EC. 30-day mortality in patients treated for brain metastases: extracranial causes dominate. Radiat Oncol. 2022;17(1):92.","journal-title":"Radiat Oncol"},{"key":"2253_CR18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/imj.14377","volume":"50","author":"G Pitson","year":"2020","unstructured":"Pitson G, Matheson L, Garrard B, Eastman P, Rogers M. Population-based analysis of radiotherapy and chemotherapy treatment in the last month of life within regional Australia. Intern Med J. 2020;50:596\u2013602.","journal-title":"Intern Med J"},{"key":"2253_CR19","doi-asserted-by":"publisher","first-page":"e2115641","DOI":"10.1001\/jamanetworkopen.2021.15641","volume":"4","author":"SY Wu","year":"2021","unstructured":"Wu SY, Yee E, Vasudevan HN, Fogh SE, Boreta L, Braunstein SE, Hong JC. Risk stratification for imminent risk of death at the time of palliative radiotherapy consultation. JAMA Netw Open. 2021;4:e2115641.","journal-title":"JAMA Netw Open"},{"key":"2253_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3171\/2013.9.JNS13788","volume":"120","author":"D Kondziolka","year":"2014","unstructured":"Kondziolka D, Parry PV, Lunsford LD, Kano H, Flickinger JC, Rakfal S, et al. The accuracy of predicting survival in individual patients with cancer. J Neurosurg. 2014;120:24\u201330.","journal-title":"J Neurosurg"},{"key":"2253_CR21","doi-asserted-by":"publisher","first-page":"668481","DOI":"10.3389\/fonc.2021.668481","volume":"11","author":"M V\u00e1zquez","year":"2021","unstructured":"V\u00e1zquez M, Altabas M, Moreno DC, Geng AA, P\u00e9rez-Hoyos S, Giralt J. 30-day mortality following palliative radiotherapy. Front Oncol. 2021;11:668481.","journal-title":"Front Oncol"},{"key":"2253_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1748-717X-8-85","volume":"8","author":"C Nieder","year":"2013","unstructured":"Nieder C, Pawinski A, Dalhaug A. Continuous controversy about radiation oncologists\u2019 choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies? Radiat Oncol. 2013;8:85.","journal-title":"Radiat Oncol"},{"key":"2253_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ctro.2021.01.004","volume":"27","author":"C Peters","year":"2021","unstructured":"Peters C, Vandewiele J, Lievens Y, van Eijkeren M, Fonteyne V, Boterberg T, et al. Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre. Clin Transl Radiat Oncol. 2021;27:64\u20139.","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02253-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02253-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02253-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:11:34Z","timestamp":1680520294000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02253-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2253"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02253-0","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. As a retrospective quality of care analysis, no approval from the Regional Committee for Medical and Health Research Ethics (REK Nord) was necessary. This research project was carried out according to our institutions\u2019 guidelines and with permission to access the patients\u2019 data. Written informed consent was received from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}